COVID antibody firm Abingdon Health tests £100m float | Bala
12298
post-template-default,single,single-post,postid-12298,single-format-standard,ajax_fade,page_not_loaded,,qode_grid_1200,qode-child-theme-ver-1.0.0,qode-theme-ver-16.7,qode-theme-bridge,wpb-js-composer js-comp-ver-5.5.4,vc_responsive

COVID antibody firm Abingdon Health tests £100m float

COVID antibody firm Abingdon Health tests £100m float

The company enlisted by the government to lead the Rapid Test Consortium as part of its response to the coronavirus pandemic will decide this week whether to pursue a London stock market flotation.



Generated by Feedzy